{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:29:09Z","timestamp":1793741349739,"version":"4.6.1"},"reference-count":47,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ther Adv Neurol Disord"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The Migraine in Poland study is a cross-sectional survey that assesses symptomatology, consulting, diagnosis, treatment and impact of migraine in Poland.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The purpose of this article is to define patterns of care for migraine in Polish patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The survey was conducted from August 2021 to June 2022. Participants were recruited through various channels, targeting mostly persons suffering from headaches. The web survey included questions allowing for diagnosis according to the International Classification of Headache Disorders. A detailed questionnaire evaluated healthcare system utilization, history of diagnosis, as well as the use of acute or preventive treatment, including non-pharmacological methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In total, 3225 individuals aged 13\u201380 (mean age 38.9) responded to the questionnaire (87.1% were women). Migraine without aura (MwoA) diagnosis was confirmed in 1679 (52.7%) of subjects, and 1571 (93.6%) of them consulted a medical professional for their headaches in the past. Among those who consulted for headache, 91% reported having received a medical diagnosis of migraine. 92.5% of MwoA participants declared the current use of some form of treatment. Non-steroidal anti-inflammatory drugs and acetaminophen were the most frequently used acute medications (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u20091318, 78.5%) followed by combination analgesics, especially those containing codeine (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u2009991, 59%). Triptans\/ergots were used by 57.1%. A total of 22.8% of subjects used acute treatment with a frequency indicating medication-overuse. Prophylactic treatment was at some point used by 35.68%, while 11.49% were currently on preventive medications. The most frequently prescribed preventives were iprazochrome (8.99%), followed by flunarizine (8.10%) and topiramate (5.90%). A total of 23.28% subjects used nutraceuticals for migraine prevention (most frequently magnesium).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Despite high consultation and diagnosis rates among Polish patients with migraine, there is a need for improving standards of care, especially in regard to choice of treatment. There is also a need to raise public awareness of the dangers of codeine-based medications (available over-the-counter in Poland).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17562864251338675","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T01:14:33Z","timestamp":1747012473000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":10,"title":["Consulting, diagnosis and treatment patterns in migraine: results from the Migraine in Poland cross-sectional survey"],"prefix":"10.1177","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9074-2803","authenticated-orcid":false,"given":"Marta","family":"Waliszewska-Pros\u00f3\u0142","sequence":"first","affiliation":[{"name":"Department of Neurology, Wroclaw Medical University, Borowska 213 Str., Wroc\u0142aw 50-556, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Straburzy\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Infectious Diseases, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0142awomir","family":"Budrewicz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Wroclaw Medical University, Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Marschollek","sequence":"additional","affiliation":[{"name":"Department of Neurology, Wroclaw Medical University, Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Nowaczewska","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Head and Neck Surgery, and Laryngological Oncology, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Ga\u0107","sequence":"additional","affiliation":[{"name":"Department of Environmental Health, Occupational Medicine and Epidemiology, Wroclaw Medical University, Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Lipton","sequence":"additional","affiliation":[{"name":"Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,5,11]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00038-3"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01889-x"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01402-2"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-0993-0"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/head.13613"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0b013e31818180cb"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2019.06.001"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01712-7"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01699-7"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/head.14259"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01575-4"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2024.2349791"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/head.13407"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202"},{"issue":"3","key":"e_1_3_5_16_2","first-page":"178","article-title":"Symptomatic treatment for migraine. Drugs used and related variables. Results of the European survey on work and migraine","volume":"27","author":"Vicente-Herrero MT","year":"2020","unstructured":"Vicente-Herrero MT, de la Ram\u00edrezI\u00f1iguez Torre MV, de la Ruiz Torre E, et al. Symptomatic treatment for migraine. Drugs used and related variables. Results of the European survey on work and migraine. Rev Soc Esp Dolor 2020; 27(3): 178\u2013191.","journal-title":"Rev Soc Esp Dolor"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-018-0946-z"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2021.1971179"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-018-0839-1"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01553-w"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102421989630"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01834-y"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2005.05024.x"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-021-00305-9"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.17219\/dmp\/175611"},{"issue":"6","key":"e_1_3_5_26_2","article-title":"Ocular and dental causes of headaches among school-age children in Jordan: a retrospective study","volume":"13","author":"Khatatbeh AE","year":"2021","unstructured":"Khatatbeh AE, Othman EF, Alalawneh AM, et al. Ocular and dental causes of headaches among school-age children in Jordan: a retrospective study. Cureus 2021; 13(6): e15623.","journal-title":"Cureus"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1321261"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14098"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01937-6"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-1048-2"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.11.025"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11092385"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2023.299"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59010031"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231174160"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01775-6"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2008.01217.x"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02289-w"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/head.14238"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01623-z"},{"key":"e_1_3_5_41_2","first-page":"4","article-title":"Iprazochrom in der Migr\u00e4neprophylaxe. Keine Bedenken gegen l\u00e4ngere Anwendung","volume":"68","author":"Koch G.","year":"1997","unstructured":"Koch G. Iprazochrom in der Migr\u00e4neprophylaxe. Keine Bedenken gegen l\u00e4ngere Anwendung [Iprazochrome in migraine prevention. No concerns regarding longer-term administration]. Nervenarzt 1997; 68(8 Suppl Der Seroto): 4 (German).","journal-title":"Nervenarzt"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1977.tb01405.x"},{"issue":"2","key":"e_1_3_5_43_2","first-page":"369","article-title":"Controlled study of iprazochrome effectiveness (Divascan) in prophylactic treatment of migraine","volume":"33","author":"Kozubski W","year":"1999","unstructured":"Kozubski W, Prusinski A. Controlled study of iprazochrome effectiveness (Divascan) in prophylactic treatment of migraine. Neurol Neurochir Pol 1999; 33(2): 369\u2013376.","journal-title":"Neurol Neurochir Pol"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2014.20.1.22"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-017-0813-3"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01316-5"},{"key":"e_1_3_5_47_2","unstructured":"https:\/\/stat.gov.pl\/spisy-powszechne\/nsp-2021\/nsp-2021-wyniki-ostateczne\/"},{"issue":"10","key":"e_1_3_5_48_2","first-page":"927","article-title":"Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world","volume":"95","author":"Caronna E","year":"2024","unstructured":"Caronna E, Gallardo VJ, Egeo G, et al. Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world. J Neurol Neurosurg Psychiatry 2024; 95(10): 927\u2013937.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Therapeutic Advances in Neurological Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562864251338675","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17562864251338675","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562864251338675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:04:54Z","timestamp":1767675894000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17562864251338675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,11]]},"references-count":47,"alternative-id":["10.1177\/17562864251338675"],"URL":"https:\/\/doi.org\/10.1177\/17562864251338675","relation":{},"ISSN":["1756-2864","1756-2864"],"issn-type":[{"value":"1756-2864","type":"print"},{"value":"1756-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,11]]},"article-number":"17562864251338675"}}